TMCnet News
BioNTech to Present at Cowen and Company's 37th Annual Health Care ConferenceMAINZ, Germany, Feb. 22, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at Cowen and Company’s 37th Annual Health Care Conference that is being held in Boston, MA from March 6 - 8, 2017. The presentation is scheduled for Tuesday, March 7 at 10:00 AM Eastern Standard Time. Mr. Marett will provide an overview of the Company´s strategy and its most recent substantial progress, including an update of its clinical pipeline, an overview of its strategic collaborations, a summary of its two most recent Nature publications related to its individualized mRNA cancer immunotherapeutics and the establishment o a GMP conform mRNA production facility at the Company´s headquarters in Germany. About BioNTech AG
For meeting requests or further information, please contact: BioNTech AG Regina Jehle Tel: +49 6131 9084 1273 Email: [email protected] U.S. Media and Investor Inquiries: ICR, Inc. James Heins/Stephanie Carrington Tel. 203-682-8251 Tel. 646-277-1282 [email protected] [email protected] International Media & Investor Inquiries akampion Dr. Ludger Wess / Ines-Regina Buth Tel. +49 40 88 16 59 64 Tel. +49 30 23 63 27 68 [email protected] |